A new study of 12 million newborns found that a routine birth dose vaccine is rapidly losing ground across US hospitals. | ...

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...

Detailed price information for Atea Pharmaceuticals Inc (AVIR-Q) from The Globe and Mail including charting and trades.

A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has suspended an anticipated push to stop recommending mRNA-based Covid-19 vaccines ...

Some members of the CDC’s vaccine advisory panel have publicly questioned the safety and manufacturing of the shots, including raising a debunked theory that DNA contaminants in the vaccines are ...

Practitioners nationwide are striving to do what’s best for children’s health, while staying supportive in the face of mistrust and confusion.

LILONGWE-(MaraviPost)-Malawi’s government is pushing for a significant increase in funding for the mining sector, seeking an additional MK114 billion to accelerate geological exploration, laboratory ...

The Centers for Disease Control and Prevention has been without a permanent director since the removal of Susan Monarez in August. Its recently installed acting director, Jay Bhattacharya, is also ...

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

In the three decades between 1993 and 2024, measles in the U.S. was relatively rare – a few hundred cases each year, at most. But suddenly, the disease has become so entrenched in American life that ...

Despite a 15% revenue increase, Purcari Wineries PCL faces profitability hurdles due to foreign exchange losses and rising ...